Лакрат

Лакрат (Ticagrelor) is an oral antiplatelet medication used to prevent blood clots after heart-related events. It belongs to the P2Y12 inhibitor class and supports cardiovascular health. This EU-manufactured generic helps maintain blood flow and reduce clot risks.

Ticagrelor is primarily used to reduce the risk of blood clots in people who have had a heart attack or severe chest pain. It is often prescribed alongside aspirin to prevent further cardiovascular events. Ticagrelor works by preventing platelets in the blood from sticking together, which can block arteries. This medication is also used for patients with a history of heart-related conditions to maintain healthy blood flow.

Ticagrelor helps maintain normal blood flow by reducing the formation of harmful clots. Users may notice improved circulation and reduced risk of chest pain or heart-related discomfort. Some people experience mild side effects like bruising or minor bleeding, which are common with antiplatelet drugs. It does not cure underlying conditions but supports ongoing cardiovascular health.

Store ticagrelor at room temperature away from moisture and heat. Keep the medication in its original container with the desiccant to protect it from moisture. Avoid crushing or splitting tablets unless directed by a healthcare provider. If you miss a dose, take it as soon as you remember, but skip it if it’s almost time for the next dose. Always follow your doctor’s instructions for safe use.

Ticagrelor may interact with other blood thinners, certain antidepressants, and some antifungal medications. Avoid grapefruit products, as they can increase the risk of side effects. Alcohol use should be limited, as it may enhance drowsiness or dizziness. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.